Pet Arthritis Market By Product Type (Medications, Assistive Devices, Alternative Therapies, Nutritional Supplements, Others), By Pet Type (Dogs, Cats & Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Online Pharmacies, Pet Specialty Stores, Veterinary Clinics & Hospitals, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Pet Arthritis market accounted for USD 3.53 Billion in 2024 and is expected to reach USD 8.15 Billion by 2035, growing at a CAGR of around 7.9% between 2025 and 2035. The Pet Arthritis Market focuses on the diagnosis, treatment, and management of arthritis in pets, fundamentally dogs and cats. This sector incorporates a variety of products such as medications, dietary supplements, therapeutic devices, and alternative treatments outlined to lighten joint pain and improve mobility. With the expanding life span of pets and a developing awareness of animal wellbeing, this market is extending quickly. Key players are presenting innovative solutions, such as natural supplements and regenerative treatments, catering to the rising demand for effective and holistic treatment alternatives. The market moreover reflects the trend of pet humanization, where owners seek quality care for their aging pets. 

Report Scope:

Market Dynamics

Rising demand for natural and alternative arthritis treatments is driving market growth

The rising demand for natural and alternative arthritis medications is basically driving growth in the Pet Arthritis Market as pet owners dynamically look for holistic choices for directing their pets' wellbeing. Concerns around the side impacts of traditional medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), have driven various owners to examine more normal cures. A overview conducted by the American Pet Products Association (APPA) indicates that 45% of pet owners prefer natural products when considering their pets' prosperity and wellness. This move towards characteristic arrangements isn't as it were driven by the need to avoid potential adverse effects but additionally reflects a developing awareness of the benefits of holistic care for improving the quality of life in maturing pets.

In addition, the market for natural supplements is encountering quick improvement, with a wide amplify of products focused on joint health and generally well-being getting to be progressively accessible. The National Animal Supplement Council (NASC) detailed that the pet supplement industry has created significantly over the past few years, reaching over $1.2 billion in 2022, with joint health products being a key segment. Also, a study published in the Journal of the American Veterinary Medical Association found that 60% of pet owners are willing to consider alternative treatments, such as herbal supplements and acupuncture, for arthritis management. This assembly of components underscores a critical move in customer behavior, driving the improvement of the Pet Arthritis Market towards more normal and alternative treatment options. 

High costs of arthritis treatments limit accessibility for many pet owners.

High costs associated with arthritis treatments pose a significant restraint on the Pet Arthritis Market, limiting availability for many pet owners. Advanced treatment choices, including surgical medications and long-term medicine regimens, can become restrictively costly. According to the American Pet Products Association (APPA), around 40% of pet owners report that cost is a major obstruction to getting to necessary veterinary care. This financial burden can lead to delayed treatment or the deserting of care inside and out, which negatively impacts the quality of life for pets enduring from arthritis.

Besides, pet insurance coverage for arthritis treatments is frequently lacking, assist exacerbating the issue. A study by the North American Pet Health Insurance Association (NAPHIA) shows that only about 30% of pets are insured, and numerous policies don't cover long-term or chronic conditions like arthritis. This need of coverage strengths pet owners to pay out-of-pocket, driving to intense choices about their pets' healthcare. As a result, the high costs of treatment not only confine get to to effective care but also highlight the require for more reasonable and available choices in the Pet Arthritis Market. 

Innovations in treatment modalities are introducing new, non-invasive options for managing pet arthritis.

Innovations in treatment modalities are significantly driving growth in the Pet Arthritis Market by introducing new, non-invasive options for managing arthritis in pets. Advances in veterinary medication have driven to the improvement of inventive treatments such as laser treatment, hydrotherapy, and regenerative medications like platelet-rich plasma (PRP) therapy and stem cell treatment. These non-invasive strategies not only reduce the distress related with traditional treatments but moreover advance faster recovery times and progressed generally health. According to a study published in the Journal of the American Veterinary Medical Association, about 70% of veterinarians report positive results in arthritis management when utilizing these progressed treatment options, indicating a move in how pet arthritis is approached.

Moreover, the developing acceptance and integration of innovation in veterinary care have improved the viability of these developments. For occurrence, veterinary telemedicine is gaining traction, permitting pet owners to consult with masters remotely and get to innovative medications without the require for obtrusive methods. A report by the American Veterinary Medical Association (AVMA) indicates that telehealth utilize in veterinary practice has expanded by over 30% in later years. This mechanical advancement not only makes care more accessible but also allows for personalized treatment plans tailored to individual pets' needs. The rise of imaginative, non-invasive treatment modalities is reshaping the Pet Arthritis Market, offering pet owners successful arrangements that improve their pets' quality of life whereas reducing the risks related with traditional treatments.

Industry Experts Opinion

“I was excited to participate as a clinical investigator in the Zenrelia field study because it is clear we need more treatment options for itchy dogs,"

-  Dr. Tom Lewis, veterinarian and founder of Dermatology for Animals

 “We’ve seen how this has really taken off in the human health space in the past few decades, and we have just begun to see the positive impact that biological therapies can have in the animal health space. We definitely see a bright future for this.”

- Dirk E. Polzer, the Chief Medical Officer (CMO) at Elanco Animal Health

Segment Analysis

Based on product type, the Pet Arthritis Market is divided into Medications, Assistive Devices and Alternative Therapies, Nutritional Supplements, and Others. The Medications segment contains NSAIDs and corticosteroids, Then Assistive Devices feature joint braces and mobility aids. The Alternative Therapies having treatments like acupuncture & laser therapy, and Nutritional Supplements encompass products with glucosamine and omega-3 fatty acids. The Others category covers additional products and services for managing pet arthritis.

Based on the route of administration, the Pet Arthritis Market is divided into Oral, Injectable, Topical, and Others. The Oral segment includes tablets, the Injectable segment consists of injection-based treatments, and the Topical category features creams and gels for localized application. The Others category encompasses additional methods of administration not covered in the main segments.

Regional Analysis

The North America regional landscape of the Pet Arthritis market is characterized by a growing demand for innovative treatment options and a heightened awareness of pet health. The U.S. and Canada lead the market, driven by an increment in pet ownership and a rising predominance of arthritis among aging pets. Key players within the region are contributing in investigate and improvement to offer advanced medications, assistive devices, and dietary supplements. In addition, the presence of well-established veterinary practices and a strong emphasis on pet wellness are contributing to market development. Government activities promoting animal health and welfare encourage support the sector. Moreover, the trend toward natural and alternative treatments is gaining traction, reflecting pet owners inclination for holistic approaches. In general, the North American market is balanced for continued development, with a focus on improving the quality of life for pets suffering from arthritis. 

The rapidly expanding Pet Arthritis market within the Asia Pacific region is fueled by expanding pet ownership, increased awareness of pet health, and a developing demand for innovative treatment arrangements. The focus on personalized care has driven to a rising interest in progressed medicines, nutritional supplements, and assistive devices particularly for managing arthritis in pets. Moreover, the utilize of advanced platforms and e-commerce is improving access to veterinary services, empowering pet owners to discover viable medicines more effectively. Social media and targeted promoting campaigns are getting to be crucial for engaging pet owners and raising awareness about arthritis management options. However, the market also faces challenges due to complex regulations and social diversity over different countries, requiring tailored techniques to effectively connect with varied consumer segments. 

Competitive Landscape

The Pet Arthritis market is highly competitive, including major participants such as Zoetis Inc., Boehringer Ingelheim, Elanco Animal Health, Merial (Boehringer Ingelheim), PetMed Express, Inc., Vetoquinol, and Nutramax Laboratories. These companies offer a diverse range of products, including advanced medications, nutritional supplements, and assistive devices tailored for managing arthritis in pets. Recent developments highlight a trend toward advancement and research, with Zoetis acquiring Abaxis to enhance its diagnostic capabilities and Elanco partnering with the University of California to progress joint health research. Moreover, the rise of elective treatments is prompting these companies to expand their offerings, engaging to pet owners seeking holistic solutions. As a result, the competitive scene is energetic, requiring participants to receive particular strategies to stay relevant and maintain their market positions. 

Pet Arthritis Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In September 2024, UCB announced that the U.S. FDA has granted approvals for BIMZELX® (bimekizumab-bkzx) to treat psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis.
• In May 2023, Zoetis announced the U.S. FDA approval of Librela™ (bedinvetmab injection) for the control of osteoarthritis (OA) pain in dogs.

Report Coverage:

By Product Type

• Medications
• Assistive Devices
• Alternative therapies
• Nutritional Supplements
• Others

By Pet Type

• Dogs
• Cats
• Others

By Route of Administration

• Oral
• Injectable
• Topical
• Others

Distribution Channel

• Online Pharmacies
• Pet Specialty Stores
• Veterinary Clinics & Hospitals
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Zoetis Inc.
• Boehringer Ingelheim
• Elanco Animal Health
• Merial (Boehringer Ingelheim)
• PetMed Express, Inc.
• Vetoquinol
• Nutramax Laboratories
• Bayer Animal Health
• MediVet
• PawMed
• Hyalun
• VetriScience Laboratories
• KVP International
• Thorne Research
• Canna-Pet

Frequently Asked Questions (FAQs)